BOSTON — Nov. 10, 2016 — Of counsel Dr. Fang Xie and shareholder Dr. Melissa Hunter-Ensor, in the Intellectual Property & Technology Practice of global law firm Greenberg Traurig, LLP’s Boston office, will participate in the Boston Bar Association’s (BBA) inaugural Life Sciences Conference, Nov. 10 at the Boston Marriott in Cambridge. The conference will explore the interplay between the life sciences sector and the law through panels covering corporate, regulatory, and intellectual property (IP) law.
From 9:15 – 10 a.m., Xie, member of the global Life Sciences & Medical Technology Group, will chair the panel, “Patent Subject Matter Eligibility in Biotech—Perspectives from the Industry, USPTO and Private Practice.” This session will address how recent Supreme Court decisions on patent subject matter eligibility are impacting the biotech industry. Practical tips will be provided on how to improve strength of patents and avoid some of the pitfalls in this area.
From 10:15 – 11 a.m., Hunter-Ensor will chair the panel, “The Impact of Brexit on the Life Sciences Industry,” which will discuss how Brexit is affecting life science transactions currently, and the risks/opportunities for life sciences as the process moves forward.
Additionally, Chinh H. Pham, co-leader of Greenberg Traurig’s Emerging Technology Group, and co-chair of the firm’s IP Group in Boston, serves on the conference advisory committee.
About Greenberg Traurig’s Boston Office
Established in 1999, Greenberg Traurig’s Boston office is home to more than 65 attorneys practicing in the areas of corporate, emerging technology, energy, governmental affairs, healthcare, intellectual property, labor and employment, life sciences and medical technology, litigation, public finance, real estate, and securities. An important contributor to the firm's international platform, the Boston office includes a team of nationally recognized attorneys with both public and private sector experience. The team offers clients the value of decades of legal experience and hands-on knowledge of the local business community, supported by the firm's vast network of global resources
About Greenberg Traurig’s Life Sciences & Medical Technology Group
Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from startups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig, LLP
Greenberg Traurig, LLP (GTLaw) has more than 2,000 attorneys in 38 offices in the United States, Latin America, Europe, Asia and the Middle East and is celebrating its 50th anniversary. One firm worldwide, GTLaw has been recognized for its philanthropic giving, was named the largest firm in the U.S. by Law360 in 2017, and among the Top 20 on the 2016 Am Law Global 100. Web: www.gtlaw.com Twitter: @GT_Law.